quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:08:06·49d
SECFiling
CAMP4 Therapeutics Corporation logo

SEC Form 10-K filed by CAMP4 Therapeutics Corporation

CAMP· CAMP4 Therapeutics Corporation
Full content unavailable. See the original source below.
Original source

Companies

  • CAMP
    CAMP4 Therapeutics Corporation

Recent analyst ratings

  • Apr 14UpdateRodman & Renshaw$7.00
  • Oct 2UpdateCantor Fitzgerald$7.00
  • Sep 16UpdateAnalyst-
  • May 27UpdateWedbush$8.00
  • Nov 5UpdateWilliam Blair-
  • Nov 5UpdatePiper Sandler$18.00

Related

  • SEC1d
    SEC Form DEFA14A filed by CAMP4 Therapeutics Corporation
  • SEC1d
    SEC Form DEF 14A filed by CAMP4 Therapeutics Corporation
  • PR6d
    CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • ANALYST10d
    Rodman & Renshaw initiated coverage on CAMP4 Therapeutics with a new price target
  • INSIDER20d
    SEC Form 4 filed by Tardiff Daniel
  • INSIDER20d
    SEC Form 4 filed by Maricich Yuri
  • INSIDER20d
    SEC Form 4 filed by Gold Kelly
  • INSIDER20d
    SEC Form 4 filed by Mandel-Brehm Josh
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022